IL36670A - Therapeutic basic copolymers of amino acids - Google Patents

Therapeutic basic copolymers of amino acids

Info

Publication number
IL36670A
IL36670A IL36670A IL3667071A IL36670A IL 36670 A IL36670 A IL 36670A IL 36670 A IL36670 A IL 36670A IL 3667071 A IL3667071 A IL 3667071A IL 36670 A IL36670 A IL 36670A
Authority
IL
Israel
Prior art keywords
therapeutic
amino acids
basic copolymers
copolymers
basic
Prior art date
Application number
IL36670A
Other languages
English (en)
Other versions
IL36670A0 (en
Original Assignee
Sela M
Hirshfeld T
Arnon R
Teitelbaum D
Meshorer A
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sela M, Hirshfeld T, Arnon R, Teitelbaum D, Meshorer A, Yeda Res & Dev filed Critical Sela M
Priority to IL36670A priority Critical patent/IL36670A/xx
Publication of IL36670A0 publication Critical patent/IL36670A0/xx
Priority to GB1420572A priority patent/GB1393435A/en
Priority to US00240244A priority patent/US3849550A/en
Priority to CA139,301A priority patent/CA1006508A/en
Priority to DE2217817A priority patent/DE2217817C2/de
Priority to CH543572A priority patent/CH570167A5/xx
Priority to JP4002272A priority patent/JPS5710132B1/ja
Priority to FR7213911A priority patent/FR2133926B1/fr
Publication of IL36670A publication Critical patent/IL36670A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polyamides (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL36670A 1971-04-21 1971-04-21 Therapeutic basic copolymers of amino acids IL36670A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IL36670A IL36670A (en) 1971-04-21 1971-04-21 Therapeutic basic copolymers of amino acids
GB1420572A GB1393435A (en) 1971-04-21 1972-03-27 Polyamides
US00240244A US3849550A (en) 1971-04-21 1972-03-31 Therapeutic copolymer
CA139,301A CA1006508A (en) 1971-04-21 1972-04-10 Therapeutic copolymers of amino acids
DE2217817A DE2217817C2 (de) 1971-04-21 1972-04-13 Pharmazeutisches Präparat zur Behandlung von oder zum Schutz gegen autoimmune Erkrankungen, die das Gehirn angreifen
CH543572A CH570167A5 (fr) 1971-04-21 1972-04-13
JP4002272A JPS5710132B1 (fr) 1971-04-21 1972-04-20
FR7213911A FR2133926B1 (fr) 1971-04-21 1972-04-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL36670A IL36670A (en) 1971-04-21 1971-04-21 Therapeutic basic copolymers of amino acids

Publications (2)

Publication Number Publication Date
IL36670A0 IL36670A0 (en) 1971-06-23
IL36670A true IL36670A (en) 1974-09-10

Family

ID=11045887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL36670A IL36670A (en) 1971-04-21 1971-04-21 Therapeutic basic copolymers of amino acids

Country Status (8)

Country Link
US (1) US3849550A (fr)
JP (1) JPS5710132B1 (fr)
CA (1) CA1006508A (fr)
CH (1) CH570167A5 (fr)
DE (1) DE2217817C2 (fr)
FR (1) FR2133926B1 (fr)
GB (1) GB1393435A (fr)
IL (1) IL36670A (fr)

Families Citing this family (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466445A (en) * 1985-06-18 1995-11-14 Emory University Methods for reducing salmonella in chickens
US5494660A (en) * 1985-06-18 1996-02-27 Emory University Method for inhibiting microbial binding to surfaces
USRE35862E (en) * 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5451410A (en) * 1993-04-22 1995-09-19 Emisphere Technologies, Inc. Modified amino acids for encapsulating active agents
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5578323A (en) * 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5714167A (en) * 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5693338A (en) * 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US6099856A (en) * 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5443841A (en) * 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5792451A (en) * 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5811127A (en) * 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5958457A (en) * 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5643957A (en) * 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
ATE298561T1 (de) * 1993-04-22 2005-07-15 Emisphere Tech Inc Orale dareichungsform
US5800808A (en) * 1994-05-24 1998-09-01 Veda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers
AU741590B2 (en) * 1994-05-24 2001-12-06 Yeda Research And Development Co. Ltd. Copolymer-1 improvements in compositions of copolymers
AU775214B2 (en) * 1994-05-24 2004-07-22 Yeda Research And Development Co. Ltd. Copolymer-1 improvements in compositions of copolymers
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5866536A (en) * 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) * 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9604880A (pt) * 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US5965121A (en) * 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) * 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5858964A (en) * 1995-04-14 1999-01-12 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
US5820881A (en) * 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5667806A (en) * 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US6051258A (en) * 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5824345A (en) * 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
DE19681560T1 (de) * 1995-09-11 1998-08-20 Emisphere Tech Inc Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
IL116559A (en) 1995-11-17 2005-11-20 Yissum Res Dev Co Chimeric protein consisting of a bacterial toxin and a myelin basic protein sequence
SI9720025A (sl) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Spojine in sestavki za prenos aktivne snovi
CA2258264A1 (fr) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Parfums microencapsules et leur procede de production
US6214791B1 (en) * 1997-01-10 2001-04-10 Yeda Research And Development Co. Ltd. Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
US5939381A (en) * 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) * 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) * 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) * 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) * 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) * 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5863944A (en) * 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) * 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
ES2527760T3 (es) * 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
EP1098902A4 (fr) 1998-07-23 2002-07-24 Yeda Res & Dev Traitement de maladies auto-immunes a l'aide du copolymere 1 et des copolymeres et peptides apparentes
JP2003521448A (ja) 1998-07-23 2003-07-15 ザ・プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ 合成ペプチドおよび自己免疫疾患治療のための使用方法
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
US6531130B1 (en) * 1999-07-06 2003-03-11 The Board Of Trustees Of The Leland Stanford University Treatment of demyelinating autoimmune disease with ordered peptides
JP4328050B2 (ja) * 2000-01-20 2009-09-09 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 神経保護療法のためのコポリマー１、関連ペプチド及びポリペプチドならびにそれらによって処理されたｔ細胞の使用
ZA200206457B (en) * 2000-02-18 2003-08-13 Yeda Res & Dev Oral, nasal and pulmonary dosage formulations of copolymer 1.
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2001093893A2 (fr) * 2000-06-07 2001-12-13 Yeda Research And Development Co. Ltd. Utilisation du copolymere 1 et des peptides et polypeptides associes, et lymphocytes t traites par ces derniers pour une therapie neuroprotectrice
WO2001097785A2 (fr) * 2000-06-20 2001-12-27 Caprion Pharmaceuticals Inc. Copolymeres et methodes de traitement des maladies a prions
WO2002076503A1 (fr) * 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Traitement de maladies du systeme nerveux central au moyen d'anticorps diriges contre l'acetate de glatiramere
IL137460A0 (en) * 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
NZ533327A (en) * 2001-12-04 2006-11-30 Teva Pharma Processes for the measurement of the potency of glatiramer acetate
NZ533356A (en) * 2001-12-06 2006-10-27 Yeda Res & Dev Vaccine and method for treatment of motor neurone diseases
WO2004043995A2 (fr) * 2002-11-13 2004-05-27 Apotex Pharmachem Inc. Procede de preparation de polypeptide 1
WO2004091573A1 (fr) * 2003-03-04 2004-10-28 Teva Pharmaceutical Industries, Ltd. Traitement combine a base d'acetate de glatiramer et d'alphacalcidol, destine au traitement de la sclerose en plaques
WO2004089407A2 (fr) 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Immunomodulateurs zwitterioniques destines au traitement de l'asthme et des allergies
CA2541445A1 (fr) * 2003-10-31 2005-05-12 Teva Pharmaceutical Industries Ltd. Nanoparticules pour la delivrance de medicaments
CA2546077C (fr) 2003-11-12 2016-07-05 Yeda Research And Development Co. Ltd. Vaccin et procede pour traiter des maladies neurodegeneratives
NZ549731A (en) * 2004-03-01 2009-11-27 Peptimmune Inc Methods and compositions for treatment of autoimmune diseases
US20050260770A1 (en) * 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof
US7655221B2 (en) * 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
CA2565819A1 (fr) 2004-05-07 2005-12-01 Peptimmune, Inc. Methodes de traitement de maladies par copolymeres aleatoires
US20060194725A1 (en) * 2004-05-07 2006-08-31 James Rasmussen Methods of treating disease with random copolymers
WO2005112911A2 (fr) * 2004-05-21 2005-12-01 The Regents Of The University Of California Compositions et procedes de traitement de troubles de deficience de la myeline
RU2387453C2 (ru) 2004-06-25 2010-04-27 АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН ОФ КВЕБЕК Композиции и способы лечения неврологических нарушений
HUE028833T2 (en) * 2004-09-09 2017-01-30 Yeda Res & Dev Polypeptide mixtures, compositions containing them, process for their preparation, and applications
KR101317131B1 (ko) * 2004-09-09 2013-10-10 테바 파마슈티컬 인더스트리즈 리미티드 정제된 브롬화 수소산을 이용한 폴리펩타이드류의 혼합물의제조방법
JP5297653B2 (ja) * 2004-10-29 2013-09-25 サンド・アクチエンゲゼルシヤフト グラチラマーの製造法
CN101111252A (zh) * 2005-02-02 2008-01-23 泰华制药工业有限公司 一种通过氢解反应生产多肽混合物的方法
US20070141663A1 (en) * 2005-08-15 2007-06-21 Jinguo Ding Process for the preparation of copolymer-1
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
EP2013628B1 (fr) 2006-04-28 2016-01-06 Momenta Pharmaceuticals, Inc. Procédés d'évaluation de mélanges peptidiques
KR100831796B1 (ko) * 2006-05-29 2008-05-28 엘지전자 주식회사 타임 쉬프트 기능을 내장한 영상표시기기 및 그 재생 방법
EP2046366B1 (fr) 2006-06-28 2016-08-31 Yeda Research And Development Company Limited Copolymer-1 pour le traitement de la dégénérescence maculaire liée à l'âge
EP2134176A4 (fr) * 2007-03-30 2012-08-29 Brigham & Womens Hospital Composés et procédés pour accentuer les thérapies de classe ii de mhc
CA2690402A1 (fr) * 2007-06-21 2008-12-24 Momenta Pharmaceuticals, Inc. Dosage de copolymere
EP2173766A1 (fr) * 2007-07-31 2010-04-14 Natco Pharma Limited Procédé de préparation de l'acétate de glatiramer (copolymère-1)
WO2009017775A2 (fr) * 2007-08-02 2009-02-05 Scinopharm Taiwan Ltd. Procédé de préparation d'un polypeptide
US8193147B2 (en) 2007-09-24 2012-06-05 Hadasit Medical Research Services & Development Ltd. Use of copolymer 1 for treatment of muscular dystrophy
RU2010146489A (ru) * 2008-04-16 2012-05-27 Момента Фармасьютикалз, Инк. (Us) Анализ композиций сополимера аминокислот
CN102112485B (zh) * 2008-08-07 2013-11-27 台湾神隆股份有限公司 乙酸格拉默(glatiramer acetate)的合成
US9617313B2 (en) 2008-12-24 2017-04-11 Synthon Bv Process for purifying a polymer mixture
WO2010115175A1 (fr) * 2009-04-03 2010-10-07 Momenta Pharmaceticals, Inc. Régulation de compositions de copolymères
US9150609B2 (en) 2009-06-04 2015-10-06 Council Of Scientific & Industrial Research Process for the preparation of copolymer-1 using a polymer supported dialkylamine initiator
US8691790B2 (en) * 2009-07-27 2014-04-08 James Layne Boucher Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
DE202010018377U1 (de) 2009-08-20 2016-02-25 Yeda Research And Development Co., Ltd. Niedrigfrequente therapie mit glatirameracetat
JP5916622B2 (ja) 2010-01-04 2016-05-11 マピ ファーマ リミテッド グラチラマーまたはその薬理学的に許容される塩を含むデポーシステム
US8377885B2 (en) 2010-01-04 2013-02-19 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
US20130035390A1 (en) 2010-01-13 2013-02-07 Ramot At Tel-Aviv University Ltd. Treatment of multiple sclerosis
KR20140019296A (ko) 2010-10-11 2014-02-14 테바 파마슈티컬 인더스트리즈 리미티드 글라티라머 아세테이트에 대한 임상 반응의 예측성 바이오마커로서의 사이토카인 바이오마커
WO2012054518A1 (fr) * 2010-10-18 2012-04-26 Lanco Biosciences, Inc. Administration de copolymères par systèmes de micro-injection
WO2012123959A2 (fr) 2011-02-14 2012-09-20 Usv Limited Copolymère-1, son procédé de préparation et méthodes d'analyse de celui-ci
ES2601892T3 (es) * 2011-04-21 2017-02-16 Mapi Pharma Limited Pentapolímero aleatorio para el tratamiento de enfermedades autoinmunes
US20140348861A1 (en) 2011-05-05 2014-11-27 National Institute Of Immunology Synthetic peptides and random copolymers for the treatment of autoimmune disorders
WO2013009864A1 (fr) 2011-07-11 2013-01-17 Momenta Pharmaceuticals, Inc. Évaluation de structure de mélanges polypeptidiques hétérogènes
WO2013009885A2 (fr) 2011-07-11 2013-01-17 Momenta Pharmaceuticals, Inc. Evaluation de diéthylamide de copolymère
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
US8575198B1 (en) 2011-09-07 2013-11-05 Momenta Pharmaceuticals, Inc. In-process control for the manufacture of glatiramer acetate
EP2765857A4 (fr) 2011-10-10 2015-12-09 Teva Pharma Polymorphismes de nucléotide simple utiles pour prédire une réponse clinique à l'acétate de glatiramère
WO2013139728A1 (fr) 2012-03-19 2013-09-26 Synthon Bv Test d'activité biologique de l'acétate de glatiramère à base de cellules monocytaires humaines
EP2642290A1 (fr) 2012-03-19 2013-09-25 Synthon BV Analyse de la puissance de l'acétate de glatiramère basée sur des lignées de cellules monocytaires humaines
US9617596B2 (en) 2012-10-10 2017-04-11 Teva Pharmaceutical Industries, Ltd. Biomarkers predictive for clinical response for glatiramer acetate
WO2014060942A2 (fr) * 2012-10-20 2014-04-24 Mahesh Kandula Compositions et méthodes pour le traitement de la sclérose en plaques et de maladies neurodégénératives
PL2774640T3 (pl) 2013-03-08 2015-04-30 Teva Pharma Wielorazowe urządzenie strzykawkowe dla strzykawki
SI2774639T1 (sl) 2013-03-08 2015-05-29 Teva Pharmaceutical Industries, Ltd. Injektorska naprava za brizgo, primerna za večkratno uporabo
CA2903805A1 (fr) 2013-03-14 2014-10-02 Mylan Inc. Essai de puissance d'acetate de glatiramere par biomarqueurs de reponse arnm
WO2014173463A1 (fr) 2013-04-26 2014-10-30 Synthon Bv Test d'activité biologique basé sur les lignées cellulaires monocytaires humaines au moyen d'acétate de glatiramère
CN103265624B (zh) * 2013-05-27 2015-04-22 成都圣诺生物制药有限公司 格拉替雷的制备方法
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
CA2928084A1 (fr) 2013-10-24 2015-04-30 Mylan Inc. Dosage de lignee de cellules t humaines pour evaluer l'identite immunologique de preparations d'acetate de glatiramere
EP3090064B1 (fr) 2013-12-31 2019-11-13 Yeda Research and Development Co. Ltd. Diagnostic du lupus érythémateux systémique à l'aide d'oligonucléotides antigènes
CN114081946A (zh) 2014-03-12 2022-02-25 耶达研究与开发有限公司 降低系统性调节性t细胞水平或活性来治疗cns疾病和损伤
WO2016029920A1 (fr) 2014-08-29 2016-03-03 Aarhus Universitet Copolymères à charge positive destinés à être utilisés en tant qu'agents antimicrobiens
US9155775B1 (en) 2015-01-28 2015-10-13 Teva Pharmaceutical Industries, Ltd. Process for manufacturing glatiramer acetate product
WO2016139659A1 (fr) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnostic du lupus érythémateux systémique à l'aide d'antigènes protéiques, peptidiques et oligonucléotidiques
WO2017031431A1 (fr) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Compositions de psa lipidés et procédés associés
EP3147667B1 (fr) 2015-09-24 2019-06-12 CHEMI S.p.A. Analyse de la distribution du poids moléculaire de mélanges de polypeptides complexes
EP3170836B1 (fr) 2015-11-23 2018-10-24 Chemi SPA Analyse rp-hplc de mélanges de polypeptides complexes
WO2018002930A1 (fr) 2016-06-30 2018-01-04 Stem Cell Medicine Ltd. Traitement d'une maladie intestinale inflammatoire avec du glatiramère à action prolongée et des cellules souches dérivées du tissu adipeux
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
US11167003B2 (en) 2017-03-26 2021-11-09 Mapi Pharma Ltd. Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
CA3062964A1 (fr) 2017-05-15 2018-11-22 Stem Cell Medicine Ltd. Traitement de la sclerose en plaques avec un glatiramere a action prolongee et des cellules souches derivees du tissu adipeux
AU2018270396A1 (en) 2017-05-15 2020-01-02 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells
WO2019175869A1 (fr) 2018-03-12 2019-09-19 Yeda Research And Development Co. Ltd Traitement d'une maladie cardiaque

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB822192A (en) * 1956-08-29 1959-10-21 Ilford Ltd Improvements in or relating to the production of photographic emulsions

Also Published As

Publication number Publication date
DE2217817A1 (fr) 1972-11-16
FR2133926A1 (fr) 1972-12-01
JPS5710132B1 (fr) 1982-02-25
FR2133926B1 (fr) 1975-12-26
CH570167A5 (fr) 1975-12-15
DE2217817C2 (de) 1983-05-05
IL36670A0 (en) 1971-06-23
US3849550A (en) 1974-11-19
GB1393435A (en) 1975-05-07
CA1006508A (en) 1977-03-08

Similar Documents

Publication Publication Date Title
IL36670A (en) Therapeutic basic copolymers of amino acids
CA1013886B (en) Hydrolyzable polymers of amino acids and hydroxy acids
JPS56158777A (en) Manufacture of substituted-4oxo-4h-1-benzopyrane- 2-carboxylic acids
HK34278A (en) Derivatives of 17alpha-hydroxy-androst-4ene-17beta-carboxylic acids
ZA722253B (en) N-protected amino acids and peptides
JPS54152094A (en) Preparation of block copolymer
CA948939A (en) Therapeutic legging
IL39347A0 (en) Novel benzamidohydroxamic acids and their preparation
ZA727086B (en) Preparation of n-(1-ethyl-pyrrolidyl-methyl)-2-methoxy-5-sulfonamidobenzamide
ZA73142B (en) Preparation of 2-alkoxy-5-alkylsulphonyl-benzoic acids
KR780000067B1 (en) Preparation of n-(1-ethyl-pyrrolidinyl-2-)methyl-2-methoxy-5-sulphamoyl-benzamide
ZA725479B (en) Treatment of whey protein
GB1366142A (en) Preparation of acrylonitrile copolymers
ZA725797B (en) Hydroxy-ether-carboxylic acids
ZA735959B (en) 4-ethers of 3-amino-5-sulfamoylbenzoic acids
ZA726595B (en) New amino esters
ZA73537B (en) Preparation of n-(1-ethyl-2-pyrrolidyl-methyl)-5-methoxy-5-ethylsulphonyl-benzamide
AU3758172A (en) Preparation of o-chlorophenols
ZA717542B (en) Preparation of n-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
CY755A (en) Therapeutic composition
GB1406993A (en) Amino acid derivatives
CA873370A (en) Water-insolubilizing basic amino acids
CA876119A (en) Direct mono-esterification of arylmalonic acids
KR780000048B1 (en) Preparation of 1-alkyl-2-aminomethyl pyprolidines
IL40503A0 (en) Preparation of n-(1-ethyl-alpha-pyrrolidylmethyl)-2-methoxy-5-sulfonamidobenzamide